Clinical trial
A Phase 3 Study to Compare the Efficacy and Safety of Humacyte's Human Acellular Vessel With That of an Autologous Arteriovenous Fistula in Subjects With End Stage Renal Disease
NCT03183245 is registered in ClinicalTrials.gov with Humacyte, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Study to Compare the Efficacy and Safety of Humacyte's Human Acellular Vessel With That of an Autologous Arteriovenous Fistula in Subjects With End Stage Renal Disease
- Lead sponsor
- Humacyte, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 29, 2017
- Completion date
- June 19, 2025
- Enrollment
- 242 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, hemodialysis, renal failure, vascular access